Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis.

• Autori principali: Rachel S Laufer (Autore), Ranju Baral (Autore), Andrea G Buchwald (Autore), James D Campbell (Autore), Flanon Coulibaly (Autore), Fatoumata Diallo (Autore), Moussa Doumbia (Autore), Amanda J Driscoll (Autore), Alison P Galvani (Autore), Adama M Keita (Autore), Kathleen M Neuzil (Autore), Samba Sow (Autore), Clint Pecenka (Autore), Justin R Ortiz (Autore), Meagan C Fitzpatrick (Autore)
• Natura: Libro
• Pubblicazione: Public Library of Science (PLoS), 2023-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Respiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs), and pediatric vaccines are under development for preventi...